Arrowhead Stock Alpha and Beta Analysis


USD 29.99  1.99  7.11%   

This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Arrowhead Pharma. It also helps investors analyze the systematic and unsystematic risks associated with investing in Arrowhead Pharma over a specified time horizon. Remember, high Arrowhead Pharma's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation.
Please continue to Arrowhead Pharma Backtesting, Arrowhead Pharma Valuation, Arrowhead Pharma Correlation, Arrowhead Pharma Hype Analysis, Arrowhead Pharma Volatility, Arrowhead Pharma History and analyze Arrowhead Pharma Performance.
Please note that although Arrowhead Pharma alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., DOW index.) So in this particular case, Arrowhead Pharma did 0.61  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Arrowhead Pharma stock's relative risk over its benchmark. Arrowhead Pharma has a beta of 2.04  . Let's try to break down what Arrowhead's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Arrowhead Pharma will likely underperform.
Arrowhead Pharma Price to Book Value is relatively stable at the moment as compared to the past year. Arrowhead Pharma reported last year Price to Book Value of 18.31. As of 11/29/2022, Tangible Assets Book Value per Share is likely to grow to 8.33, while Enterprise Value over EBIT is likely to drop (38.79) .
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.

Enterprise Value

7.7 Billion

Arrowhead Pharma Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Arrowhead Pharma market risk premium is the additional return an investor will receive from holding Arrowhead Pharma long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Arrowhead Pharma. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Arrowhead Pharma's performance over market.
α-0.61   β2.04
90 days against DJI

Arrowhead Pharma expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Arrowhead Pharma's Buy-and-hold return. Our buy-and-hold chart shows how Arrowhead Pharma performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Arrowhead Pharma Market Price Analysis

Market price analysis indicators help investors to evaluate how Arrowhead Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Arrowhead Pharma shares will generate the highest return on investment. By understating and applying Arrowhead Pharma stock market price indicators, traders can identify Arrowhead Pharma position entry and exit signals to maximize returns.

Arrowhead Pharma Return and Market Media

The median price of Arrowhead Pharma for the period between Wed, Aug 31, 2022 and Tue, Nov 29, 2022 is 33.74 with a coefficient of variation of 9.37. The daily time series for the period is distributed with a sample standard deviation of 3.19, arithmetic mean of 34.02, and mean deviation of 2.42. The Stock received some media coverage during the period.
 Price Growth (%)  
Swelling losses havent held back gains for Arrowhead Pharmac...09/23/2022
Exercise or conversion by Christopher Anzalone of 1542 share...09/29/2022
EPS Estimate09/30/2022
Arrowhead Pharmaceuticals to Present Interim Phase 2 Clinica...10/11/2022
Sale by San Martin Javier of 19300 shares of Arrowhead Pharm...11/22/2022
EPS Reported11/28/2022

About Arrowhead Pharma Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Arrowhead or other stocks. Alpha measures the amount that position in Arrowhead Pharma has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2019 2020 2021 2022 (projected)
Receivables Turnover116.4624.9222.4223.01
PPandE Turnover3.243.483.132.51

Arrowhead Pharma Upcoming Company Events

As portrayed in its financial statements, the presentation of Arrowhead Pharma's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Arrowhead Pharma's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Arrowhead Pharma's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Arrowhead Pharma. Please utilize our Beneish M Score to check the likelihood of Arrowhead Pharma's management manipulating its earnings.
Upcoming Quarterly Report3rd of February 2022
Next Financial Report3rd of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End28th of November 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

Build Portfolio with Arrowhead Pharma

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please continue to Arrowhead Pharma Backtesting, Arrowhead Pharma Valuation, Arrowhead Pharma Correlation, Arrowhead Pharma Hype Analysis, Arrowhead Pharma Volatility, Arrowhead Pharma History and analyze Arrowhead Pharma Performance. You can also try Equity Valuation module to check real value of public entities based on technical and fundamental data.

Complementary Tools for analysis

When running Arrowhead Pharma price analysis, check to measure Arrowhead Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arrowhead Pharma is operating at the current time. Most of Arrowhead Pharma's value examination focuses on studying past and present price action to predict the probability of Arrowhead Pharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Arrowhead Pharma's price. Additionally, you may evaluate how the addition of Arrowhead Pharma to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Arrowhead Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Arrowhead Pharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Arrowhead Pharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...